See more : CRRC Corporation Limited (1766.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Ossen Innovation Co., Ltd. (OSN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ossen Innovation Co., Ltd., a leading company in the Steel industry within the Basic Materials sector.
- Black Iron Inc. (BKIRF) Income Statement Analysis – Financial Results
- Mi Technovation Berhad (5286.KL) Income Statement Analysis – Financial Results
- i-CABLE Communications Limited (ICABY) Income Statement Analysis – Financial Results
- Zhongtai Securities Co., Ltd. (600918.SS) Income Statement Analysis – Financial Results
- Unifiedpost Group SA (UPG.BR) Income Statement Analysis – Financial Results
Ossen Innovation Co., Ltd. (OSN)
About Ossen Innovation Co., Ltd.
Ossen Innovation Co., Ltd. manufactures coated steel materials. The company is headquartered in Shanghai, Shanghai and currently employs 209 full-time employees. The firm manufactures and sells an array of plain surface prestressed steel materials, and rare earth coated and zinc coated prestressed steel materials. The firm's materials are used in the construction of bridges, highways and other infrastructure projects in the People's Republic of China and internationally. Its facilities are located in Maanshan City, Anhui Province and in Jiujiang City, Jiangxi Province, in the People's Republic of China. Its pre-stressed steel materials are categorized as plain surface products and coated products. Its products are marketed under the Ossen brand name both domestically and internationally. The firm's plain surface products include its uncoated plain surfaced and stabilized products. Its coated pre-stressed products included zinc coated PC products and rare earth coated PC products.
Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 138.58M | 138.90M | 136.10M | 132.38M | 117.03M | 117.91M | 123.57M | 113.89M | 122.40M | 118.62M | 117.45M | 101.09M | 82.74M |
Cost of Revenue | 114.86M | 116.54M | 115.59M | 117.72M | 100.93M | 102.20M | 110.25M | 102.35M | 111.61M | 96.59M | 92.89M | 87.66M | 70.53M |
Gross Profit | 23.72M | 22.36M | 20.52M | 14.65M | 16.10M | 15.71M | 13.32M | 11.54M | 10.79M | 22.03M | 24.56M | 13.43M | 12.21M |
Gross Profit Ratio | 17.12% | 16.10% | 15.08% | 11.07% | 13.75% | 13.32% | 10.78% | 10.13% | 8.81% | 18.57% | 20.91% | 13.28% | 14.76% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 6.96M | 6.16M | 5.26M | 6.00M | 6.38M | 4.48M | 6.34M | 3.49M | 3.95M | 2.75M | 1.20M | 1.14M | 1.32M |
Selling & Marketing | 380.95K | 357.43K | 327.37K | 598.83K | 734.16K | 986.38K | 772.38K | 625.50K | 917.07K | 1.22M | 660.93K | 0.00 | 0.00 |
SG&A | 7.34M | 6.51M | 5.59M | 6.60M | 7.11M | 5.46M | 7.11M | 4.11M | 4.87M | 3.96M | 1.86M | 1.14M | 1.32M |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 503.72K | 4.33M |
Operating Expenses | 7.34M | 6.51M | 5.59M | 6.60M | 7.11M | 5.46M | 7.11M | 4.11M | 4.87M | 3.96M | 1.86M | 1.65M | 5.64M |
Cost & Expenses | 122.19M | 123.05M | 121.18M | 124.32M | 108.04M | 107.66M | 117.36M | 106.46M | 116.48M | 100.55M | 94.76M | 89.31M | 76.18M |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 2.86M | 2.38M | 1.62M | 1.61M | 2.83M | 2.82M | 2.40M | 2.70M | 3.56M | 3.48M | 2.44M | 1.50M | 1.89M |
Depreciation & Amortization | 493.48K | 606.05K | 641.65K | 796.57K | 883.76K | 1.42M | 1.53M | 1.56M | 1.60M | 2.01M | 1.84M | 1.46M | 1.56M |
EBITDA | 16.00M | 15.61M | 14.77M | 8.44M | 9.46M | 11.32M | 8.37M | 9.12M | 8.10M | 19.17M | 21.79M | 11.71M | 7.69M |
EBITDA Ratio | 11.55% | 11.24% | 10.85% | 6.38% | 8.08% | 9.60% | 6.77% | 8.01% | 6.61% | 16.17% | 18.55% | 11.58% | 9.30% |
Operating Income | 15.51M | 15.01M | 14.13M | 7.65M | 8.58M | 9.90M | 6.84M | 7.56M | 6.49M | 17.17M | 19.95M | 10.25M | 6.14M |
Operating Income Ratio | 11.19% | 10.80% | 10.38% | 5.78% | 7.33% | 8.40% | 5.53% | 6.64% | 5.31% | 14.47% | 16.99% | 10.14% | 7.42% |
Total Other Income/Expenses | -1.91M | -1.24M | -615.96K | -1.06M | -2.33M | -2.11M | -2.12M | -2.27M | -3.22M | -1.97M | 459.97K | 217.96K | -1.08M |
Income Before Tax | 13.60M | 13.76M | 13.51M | 6.59M | 6.25M | 7.79M | 4.71M | 5.29M | 3.27M | 15.19M | 20.41M | 10.47M | 5.06M |
Income Before Tax Ratio | 9.81% | 9.91% | 9.93% | 4.98% | 5.34% | 6.61% | 3.82% | 4.64% | 2.67% | 12.81% | 17.38% | 10.35% | 6.11% |
Income Tax Expense | 1.57M | 1.53M | 2.13M | 691.56K | 926.05K | 1.18M | 578.73K | 1.22M | 557.43K | 2.14M | 2.87M | 740.05K | 291.52K |
Net Income | 12.03M | 12.23M | 11.38M | 5.90M | 5.32M | 6.61M | 4.14M | 4.07M | 2.72M | 13.05M | 17.55M | 9.73M | 4.76M |
Net Income Ratio | 8.68% | 8.80% | 8.36% | 4.46% | 4.55% | 5.61% | 3.35% | 3.57% | 2.22% | 11.01% | 14.94% | 9.62% | 5.76% |
EPS | 1.82 | 1.85 | 1.73 | 0.89 | 0.81 | 1.00 | 0.62 | 0.61 | 0.41 | 1.96 | 3.47 | 1.95 | 0.95 |
EPS Diluted | 1.82 | 1.85 | 1.73 | 0.89 | 0.81 | 1.00 | 0.62 | 0.61 | 0.41 | 1.96 | 3.47 | 1.95 | 0.95 |
Weighted Avg Shares Out | 6.60M | 6.60M | 6.60M | 6.60M | 6.60M | 6.62M | 6.63M | 6.63M | 6.65M | 6.67M | 5.05M | 5.00M | 5.00M |
Weighted Avg Shares Out (Dil) | 6.60M | 6.60M | 6.60M | 6.60M | 6.60M | 6.62M | 6.63M | 6.63M | 6.65M | 6.67M | 5.05M | 5.00M | 5.00M |
Aldeyra Therapeutics Selected to Present at the Disruptive Innovations Symposium during the OSN New York Retina 2024 Meeting
OSN+ partners with castLabs to enhance content protection with cutting-edge multi-DRM technology, DRMtoday
Yintai obtains third and final PRC Approval
Osino obtains Final Court Order approving Plan of Arrangement and Yintai obtains NDRC Approval
Ossen Innovation Announces Completion of Merger
Ossen Innovation Announces Unaudited Financial Results for the Six Months Ended June 30, 2021
Ossen Innovation Could Offer +15% Return On Long-Awaited Take-Private Deal
Ossen Innovation to Hold Extraordinary General Meeting of Shareholders
Ossen Innovation Enters into Amendment No. 1 to Merger Agreement for Going Private Transaction
Ossen Innovation Announces Full Year 2020 Financial Results
Source: https://incomestatements.info
Category: Stock Reports